Swift Biosciences, Inc. — Form D
Swift Biosciences, Inc. of ANN ARBOR, MI, a company, filed a Form D exempt-offering notice with the SEC on 2018-11-13. The offering totals $7.0M, of which $4.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2018-11-13
- Form: D
- Accession: 0001496185-18-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $4.0M
- Remaining: $3.0M
- Investors: 33
- Date of first sale: 2018-11-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-325552
Issuer
- Name: Swift Biosciences, Inc.
- CIK: 0001496185
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 674 S. Wagner Rd., ANN ARBOR, MI, 48103
- Phone: 734-330-2568
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Jack Ball | Director | Longmont, CO |
| Dan Kidle | Director | Ann Arbor, MI |
| Mark Lewis | Director | DAYTON, WA |
| Linda Tufts | Director | Cleveland, OH |
| Dan Watkins | Director | Houston, TX |
| Nathan Wood | Director | Longmont, CO |
| Walter Young | Director | Longmont, CO |
| Nathan Wood | Executive Officer | Longmont, CO |
| Timothy Harkins, PhD | Director | Ann Arbor, MI |
| Timothy Harkins, PhD | Executive Officer | Ann Arbor, MI |
| Peter Kleinhenz | Director | Pittsburgh, PA |
| Jack Ball, Jr. | Director | Ann Arbor, MI |
| Eric Halverson | Executive Officer | Ann Arbor, MI |
| Vladimir Makarov | Director | Ann Arbor, MI |
| Vladimir Makarov | Executive Officer | Ann Arbor, MI |
| Tim Harkins | Director | Ann Arbor, MI |
| Tim Harkins | Executive Officer | Ann Arbor, MI |
| David Olson | Director | Jacksonville, FL |
| David Olson | Executive Officer | Jacksonville, FL |
Other filings by this issuer (6)
More